Normal view MARC view ISBD view

Neurocardiological differences between musicians and control subjects. [electronic resource]

By:

Burggraaf, J L I

Contributor(s):

Producer: 20130314Description: 183-8 p. digitalISSN:

1568-5888

Online resources:

Available from publisher's website

In: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation vol. 21

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

1141 Mobile Health Technology for Atrial Fibrillation Management Integrating Decision Support, Education, and Patient Involvement: mAF App Trial.
by Guo, Yutao
1142 Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation: Should We Use a CHA
by Nielsen, Peter Brønnum
1143 The National Institute for Health Research (NIHR) Global Health Research Group on Atrial Fibrillation management.
by Lip, Gregory Y H
1144 Tamoxifen for breast-cancer prevention.
by Caine, Graham J
1145 Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
by Clagett, G Patrick
1146 Apolipoproteins in the discrimination of atherosclerotic burden and cardiac function in patients with stable coronary artery disease.
by Patel, Jeetesh V
1147 An analysis of factors that predict patient consent to take part in a randomized controlled trial.
by Fletcher, Kate
1148 Pre and post-operative treatments for prevention of atrial fibrillation after cardiac surgery.
by Orenes-Piñero, Esteban
1149 Potential net clinical benefit of population-wide implementation of apixaban and dabigatran among European patients with atrial fibrillation. A modelling analysis from the Euro Heart Survey.
by Pisters, Ron
1150 Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature.
by Dentali, Francesco
1151 Periprocedural anticoagulation therapy for devices and atrial fibrillation ablation.
by Lip, Gregory Y H
1152 Current practice in out-of-hospital cardiac arrest management: a European heart rhythm association EP network survey.
by Proclemer, Alessandro
1153 Balancing bleeding and thrombotic risk with new oral anticoagulants in patients with atrial fibrillation.
by Overvad, Thure F
1154 Stroke, thromboembolism and bleeding in patients with atrial fibrillation according to the EHRA valvular heart disease classification.
by Bisson, Arnaud
1155 Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin. A propensity score matched analysis.
by Lip, Gregory Y H
1156 Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA2DS2-VASc Risk Factor Be Anticoagulated?
by Fauchier, Laurent
1157 Cardiac fibrosis can be attenuated by blocking the activity of transglutaminase 2 using a selective small-molecule inhibitor.
by Wang, Zhuo
1158 Stroke and Thromboembolism in Patients With Atrial Fibrillation and Mitral Regurgitation.
by Bisson, Arnaud
1159 Elevated platelet microparticles in stable coronary artery disease are unrelated to disease severity or to indices of inflammation.
by Tan, Kiat T
1160 A cross-sectional study of hypertension in an elderly population (75 years and over) with atrial fibrillation: secondary analysis of data from the Birmingham Atrial Fibrillation in the Aged (BAFTA) randomised controlled trial.
by Hurley, Victoria